IKT: Inhibikase Therapeutics, Inc. Stock

by  •  • Comments Off on IKT: Inhibikase Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 8.78
Enterprise Value ($M) -0.01
Book Value ($M) 10.98
Book Value / Share 1.69
Price / Book 0.80
NCAV ($M) 10.68
NCAV / Share 1.65
Price / NCAV 0.82

Profitability (mra)
Return on Invested Capital (ROIC) -1.64
Return on Assets (ROA) -0.68
Return on Equity (ROE) -0.75

Liquidity (mrq)
Quick Ratio 4.13
Current Ratio 4.13

Balance Sheet (mrq) ($M)
Current Assets 14.21
Assets 14.51
Liabilities 3.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.26
Operating Income -20.09
Net Income -19.03

Cash Flow Statement (mra) ($M)
Cash From Operations -18.09
Cash from Investing 11.66
Cash from Financing 8.41

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-10-16 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REP
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 33,010 92,073 35.85
2024-04-30 15,969 54,325 29.40
2024-04-29 10,000 39,855 25.09
2024-04-26 53,353 26,076 204.61

(click for more detail)

Similar Companies
HOTH – Hoth Therapeutics, Inc. HRTX – Heron Therapeutics, Inc.
ICCC – ImmuCell Corporation IMCC – IM Cannabis Corp.
IMMX – Immix Biopharma, Inc.


Financial data and stock pages provided by
Fintel.io